106 related articles for article (PubMed ID: 22628295)
21. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
22. Defects in mitochondrial energetic function compels Fanconi Anaemia cells to glycolytic metabolism.
Cappelli E; Cuccarolo P; Stroppiana G; Miano M; Bottega R; Cossu V; Degan P; Ravera S
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1214-1221. PubMed ID: 28315453
[TBL] [Abstract][Full Text] [Related]
23. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells.
Kumari U; Ya Jun W; Huat Bay B; Lyakhovich A
Oncogene; 2014 Jan; 33(2):165-72. PubMed ID: 23318445
[TBL] [Abstract][Full Text] [Related]
24. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage.
Futaki M; Igarashi T; Watanabe S; Kajigaya S; Tatsuguchi A; Wang J; Liu JM
Carcinogenesis; 2002 Jan; 23(1):67-72. PubMed ID: 11756225
[TBL] [Abstract][Full Text] [Related]
25. [Complex role of the FA proteins in providing genome stability].
Kluzek K; Zdzienicka MZ
Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
[TBL] [Abstract][Full Text] [Related]
26. Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases.
Lloret A; Calzone R; Dunster C; Manini P; d'Ischia M; Degan P; Kelly FJ; Pallardó FV; Zatterale A; Pagano G
Free Radic Biol Med; 2008 Feb; 44(4):495-503. PubMed ID: 18053816
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated Ca2+ homeostasis in Fanconi anemia cells.
Usai C; Ravera S; Cuccarolo P; Panfoli I; Dufour C; Cappelli E; Degan P
Sci Rep; 2015 Jan; 5():8088. PubMed ID: 25627108
[TBL] [Abstract][Full Text] [Related]
28. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model.
Zhang QS; Marquez-Loza L; Sheehan AM; Watanabe-Smith K; Eaton L; Benedetti E; Major A; Schubert K; Deater M; Joseph E; Grompe M
Pediatr Blood Cancer; 2014 Apr; 61(4):740-2. PubMed ID: 24115584
[TBL] [Abstract][Full Text] [Related]
30. C. elegans: a model of Fanconi anemia and ICL repair.
Youds JL; Barber LJ; Boulton SJ
Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
[TBL] [Abstract][Full Text] [Related]
31. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.
Rosselli F; Ridet A; Soussi T; Duchaud E; Alapetite C; Moustacchi E
Oncogene; 1995 Jan; 10(1):9-17. PubMed ID: 7824283
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.
Li J; Pang Q
Antioxid Redox Signal; 2014 May; 20(14):2290-301. PubMed ID: 24206276
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of metalloproteinase activity in FANCA is linked to altered oxygen metabolism.
Ravera S; Capanni C; Tognotti D; Bottega R; Columbaro M; Dufour C; Cappelli E; Degan P
J Cell Physiol; 2015 Mar; 230(3):603-9. PubMed ID: 25161103
[TBL] [Abstract][Full Text] [Related]
34. Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study.
Columbaro M; Ravera S; Capanni C; Panfoli I; Cuccarolo P; Stroppiana G; Degan P; Cappelli E
PLoS One; 2014; 9(7):e104857. PubMed ID: 25126945
[TBL] [Abstract][Full Text] [Related]
35. Increased red cell distribution width in Fanconi anemia: a novel marker of stress erythropoiesis.
Sousa R; Gonçalves C; Guerra IC; Costa E; Fernandes A; do Bom Sucesso M; Azevedo J; Rodriguez A; Rius R; Seabra C; Ferreira F; Ribeiro L; Ferrão A; Castedo S; Cleto E; Coutinho J; Carvalho F; Barbot J; Porto B
Orphanet J Rare Dis; 2016 Jul; 11(1):102. PubMed ID: 27456001
[TBL] [Abstract][Full Text] [Related]
36. Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity.
Umansky C; Morellato AE; Rieckher M; Scheidegger MA; Martinefski MR; Fernández GA; Pak O; Kolesnikova K; Reingruber H; Bollini M; Crossan GP; Sommer N; Monge ME; Schumacher B; Pontel LB
Nat Commun; 2022 Feb; 13(1):745. PubMed ID: 35136057
[TBL] [Abstract][Full Text] [Related]
37. Re-definition and supporting evidence toward Fanconi Anemia as a mitochondrial disease: Prospects for new design in clinical management.
Pagano G; Tiano L; Pallardó FV; Lyakhovich A; Mukhopadhyay SS; Di Bartolomeo P; Zatterale A; Trifuoggi M
Redox Biol; 2021 Apr; 40():101860. PubMed ID: 33445068
[TBL] [Abstract][Full Text] [Related]
38. Concentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells.
Ravera S; Cossu V; Tappino B; Nicchia E; Dufour C; Cavani S; Sciutto A; Bolognesi C; Columbaro M; Degan P; Cappelli E
J Cell Physiol; 2018 Feb; 233(2):1736-1751. PubMed ID: 28681917
[TBL] [Abstract][Full Text] [Related]
39. Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?
Pagano G; Shyamsunder P; Verma RS; Lyakhovich A
Oncoscience; 2014; 1(4):287-95. PubMed ID: 25594021
[TBL] [Abstract][Full Text] [Related]
40. Gender-related differences in the oxidant state of cells in Fanconi anemia heterozygotes.
Petrovic S; Leskovac A; Kotur-Stevuljevic J; Joksic J; Guc-Scekic M; Vujic D; Joksic G
Biol Chem; 2011 Jul; 392(7):625-32. PubMed ID: 21619480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
